State Of Wyoming Amarin Corp Plcuk Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $490 - $1,601	434 Added 31.75%	1,801 $3,000
Q1 2022 May 13, 2022	BUY	$2.85 - $3.73 $550 - $719	193 Added 16.44%	1,367 $4,000
Q4 2021 Feb 11, 2022	SELL	$3.24 - $5.18 $1,049 - $1,678	-324 Reduced 21.63%	1,174 $4,000
Q3 2021 Feb 11, 2022	SELL	$3.94 - $5.84 $2,840 - $4,210	-721 Reduced 32.49%	1,498 $8,000
Q2 2021 Feb 11, 2022	BUY	$4.26 - $6.5 $4,745 - $7,241	1,114 Added 100.81%	2,219 $10,000
Q1 2021 Feb 08, 2022	BUY	$5.03 - $8.8 $5,558 - $9,724	1,105 New	1,105 $7,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.